# Brookfield Business Partners L.P.: financial statements, quarterly

BBUC · NYSE · CIK 1654795 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbuc.md) · [Financials](/companies/bbuc/financials.md) · [Filings](/companies/bbuc/filings.md) · [Insiders](/companies/bbuc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbuc/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001628280-18-003046.md) | [0.4](/filings/0001628280-19-003025.md) | [1.1](/filings/0001628280-20-003093.md) | [1.1](/filings/0001628280-21-004944.md) | [1.9](/filings/0001628280-22-010069.md) | [2.0](/filings/0001628280-23-006618.md) | [2.7](/filings/0001628280-24-008228.md) | [2.6](/filings/0001628280-25-017216.md) | [2.9](/filings/0001628280-26-022148.md) | [3.3](/filings/0001628280-26-022148.md) | [3.2](/filings/0001628280-26-022148.md) | [3.5](/filings/0001628280-26-022148.md) |
| Current assets | $bn | not reported | not reported | [4.1](/filings/0001628280-18-003046.md) | [6.4](/filings/0001628280-19-003025.md) | [9.8](/filings/0001628280-20-003093.md) | [12.8](/filings/0001628280-21-004944.md) | [14.5](/filings/0001628280-22-010069.md) | [15.4](/filings/0001628280-23-006618.md) | [18.3](/filings/0001628280-24-008228.md) | [14.9](/filings/0001628280-25-017216.md) | [15.3](/filings/0001628280-26-022148.md) | [15.0](/filings/0001628280-26-022148.md) |
| Total assets | $bn | not reported | not reported | [8.2](/filings/0001628280-18-003046.md) | [15.8](/filings/0001628280-19-003025.md) | [27.3](/filings/0001628280-20-003093.md) | [51.8](/filings/0001628280-21-004944.md) | [54.7](/filings/0001628280-22-010069.md) | [64.2](/filings/0001628280-23-006618.md) | [89.3](/filings/0001628280-24-008228.md) | [82.4](/filings/0001628280-25-017216.md) | [75.5](/filings/0001628280-26-022148.md) | [75.8](/filings/0001628280-26-022148.md) |
| Current liabilities | $bn | not reported | not reported | [2.6](/filings/0001628280-18-003046.md) | [5.7](/filings/0001628280-19-003025.md) | [9.0](/filings/0001628280-20-003093.md) | [11.0](/filings/0001628280-21-004944.md) | [12.1](/filings/0001628280-22-010069.md) | [13.9](/filings/0001628280-23-006618.md) | [16.7](/filings/0001628280-24-008228.md) | [14.4](/filings/0001628280-25-017216.md) | [12.2](/filings/0001628280-26-022148.md) | [9.0](/filings/0001628280-26-022148.md) |
| Total liabilities | $bn | not reported | not reported | [4.2](/filings/0001628280-18-003046.md) | [9.7](/filings/0001628280-19-003025.md) | [20.8](/filings/0001628280-20-003093.md) | [40.7](/filings/0001628280-21-004944.md) | [43.4](/filings/0001628280-22-010069.md) | [51.2](/filings/0001628280-23-006618.md) | [70.8](/filings/0001628280-24-008228.md) | [63.9](/filings/0001628280-25-017216.md) | [58.2](/filings/0001628280-26-022148.md) | [60.5](/filings/0001628280-26-022148.md) |
| Shareholders' equity | $bn | [2.1](/filings/0001628280-18-003046.md) | [3.1](/filings/0001628280-19-003025.md) | [4.0](/filings/0001628280-20-003093.md) | [5.8](/filings/0001628280-21-004944.md) | [6.5](/filings/0001628280-22-010069.md) | [11.1](/filings/0001628280-23-006618.md) | [11.3](/filings/0001628280-24-008228.md) | [13.0](/filings/0001628280-25-017216.md) | [18.4](/filings/0001628280-26-022148.md) | [18.5](/filings/0001628280-26-022148.md) | [17.3](/filings/0001628280-26-022148.md) | [15.3](/filings/0001628280-26-022148.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 87,720,678 at 2025-12-31, from the cover of the [20-F filed 2026-03-31](/filings/0001628280-26-022148.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.